Compare Biocon with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON VENUS REMEDIES BIOCON /
VENUS REMEDIES
 
P/E (TTM) x 49.3 8.1 611.9% View Chart
P/BV x 6.1 1.8 340.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BIOCON    VENUS REMEDIES
EQUITY SHARE DATA
    BIOCON
Mar-21
VENUS REMEDIES
Mar-20
BIOCON /
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs48837 1,305.8%   
Low Rs27520 1,407.9%   
Sales per share (Unadj.) Rs59.2276.7 21.4%  
Earnings per share (Unadj.) Rs7.7-8.1 -95.2%  
Cash flow per share (Unadj.) Rs13.717.8 76.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs62.3262.1 23.8%  
Shares outstanding (eoy) m1,200.0012.34 9,724.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.40.1 6,264.6%   
Avg P/E ratio x49.4-3.5 -1,408.6%  
P/CF ratio (eoy) x27.91.6 1,749.3%  
Price / Book Value ratio x6.10.1 5,641.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m457,350351 130,365.1%   
No. of employees `000NANA-   
Total wages/salary Rs m17,410460 3,783.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m71,0583,415 2,081.0%  
Other income Rs m6,05253 11,401.7%   
Total revenues Rs m77,1103,468 2,223.7%   
Gross profit Rs m13,145320 4,106.9%  
Depreciation Rs m7,151320 2,233.8%   
Interest Rs m577133 432.6%   
Profit before tax Rs m11,469-80 -14,273.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,21520 11,278.0%   
Profit after tax Rs m9,254-100 -9,254.9%  
Gross profit margin %18.59.4 197.4%  
Effective tax rate %19.3-24.4 -79.0%   
Net profit margin %13.0-2.9 -444.7%  
BALANCE SHEET DATA
Current assets Rs m76,0042,880 2,639.5%   
Current liabilities Rs m42,1012,185 1,926.6%   
Net working cap to sales %47.720.3 234.7%  
Current ratio x1.81.3 137.0%  
Inventory Days Days13738 357.2%  
Debtors Days Days6333 190.6%  
Net fixed assets Rs m106,1423,498 3,034.6%   
Share capital Rs m6,000123 4,861.4%   
"Free" reserves Rs m68,7283,110 2,209.7%   
Net worth Rs m74,7283,234 2,310.9%   
Long term debt Rs m29,616721 4,110.3%   
Total assets Rs m182,1466,377 2,856.2%  
Interest coverage x20.90.4 5,251.5%   
Debt to equity ratio x0.40.2 177.9%  
Sales to assets ratio x0.40.5 72.9%   
Return on assets %5.40.5 1,031.1%  
Return on equity %12.4-3.1 -400.5%  
Return on capital %11.51.3 861.0%  
Exports to sales %00-   
Imports to sales %7.20-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m5,084NA-   
Fx inflow Rs m11,7910-   
Fx outflow Rs m5,0840-   
Net fx Rs m6,7070-   
CASH FLOW
From Operations Rs m11,597770 1,505.9%  
From Investments Rs m-36,247-47 76,341.6%  
From Financial Activity Rs m25,640-730 -3,512.2%  
Net Cashflow Rs m723-7 -10,554.7%  

Share Holding

Indian Promoters % 39.7 40.8 97.4%  
Foreign collaborators % 20.9 0.0 -  
Indian inst/Mut Fund % 23.4 0.0 58,575.0%  
FIIs % 15.9 0.0 39,775.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 59.2 66.5%  
Shareholders   338,827 13,846 2,447.1%  
Pledged promoter(s) holding % 0.0 15.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   AMRUTANJAN HEALTHCARE  ZENITH HEALTH  RPG LIFE SCIENCES  BHARAT PARENTALS  WOCKHARDT  



Today's Market

Sensex Slumps 700 Points from Day's High to End Lower; Tata Steel & SBI Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

BIOCON 2020-21 Annual Report Analysis (Annual Result Update)

Aug 10, 2021 | Updated on Aug 10, 2021

Here's an analysis of the annual report of BIOCON for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of BIOCON . Also includes updates on the valuation of BIOCON .

BIOCON Announces Quarterly Results (1QFY22); Net Profit Down 4.0% (Quarterly Result Update)

Jul 26, 2021 | Updated on Jul 26, 2021

For the quarter ended June 2021, BIOCON has posted a net profit of Rs 2 bn (down 4.0% YoY). Sales on the other hand came in at Rs 18 bn (up 3.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (4QFY21); Net Profit Up 118.6% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, BIOCON has posted a net profit of Rs 4 bn (up 118.6% YoY). Sales on the other hand came in at Rs 18 bn (up 16.3% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore(Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

Revenge Travel is Here. 9 Stocks Likely to Benefit(Views On News)

Sep 4, 2021

The term 'revenge travel' refers to the desire of going on a vacation after an extended period of lockdown.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Sep 17, 2021 (Close)

TRACK BIOCON

BIOCON - CORAL LAB. COMPARISON

COMPARE BIOCON WITH

MARKET STATS